December 12, 2024

Brief, Vigorous Activity May Lower CV Risk in Women: Study Findings

Conexiant

December 12, 2024

54 Novel Drugs Await FDA Review

An analysis published in the American Journal of Health-System Pharmacy provides an overview of the potential next wave of pharmaceuticals.

Conexiant

December 11, 2024

Fasting Glucose Rises Despite BMI Trends

Conexiant

December 11, 2024

Sex Differences in Statin-Linked Diabetes Risk

Conexiant

December 10, 2024

Hormone Therapy Risks Vary: Tibolone Linked to Arterial Events

Conexiant

December 09, 2024

Breast Calcifications Linked to CVD Risk

Conexiant

December 09, 2024

Study: Dark, Not Milk, Chocolate Cuts Diabetes

Dark chocolate intake of ≥5 servings per week was linked to a significant 21% lower risk of type 2 diabetes, unlike milk chocolate, which showed no such benefit.

Conexiant

December 09, 2024

ADA Guidelines Add Tech Focus for Diabetes Care

The 2025 Standards introduce continuous glucose monitoring recommendations for type 2 diabetes patients not on insulin therapy, while new guidance addresses religious fasting, automated insulin delivery in pregnancy, and specific blood glucose targets for hospitalized patients.

Conexiant

December 06, 2024

Sex and Ethnic Disparities in Stroke Med Adherence

Conexiant